학술논문
The Level of Residual CLL Objectively Predicts the Outcome of Patients Following FCR-Based Therapy with Sequential Benefits per Log Depletion and Improved Post-Treatment Monitoring
Document Type
Abstract
Author
Source
In Blood 3 December 2015 126(23):1717-1717
Subject
Language
ISSN
0006-4971